Cargando…

Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes

The treatment of acute coronary syndrome (ACS) in elderly patients continues to be a challenge because of the characteS.G.B.ristics of this population and the lack of data and specific recommendations. This review summarizes the current evidence about critical points of oral antithrombotic therapy i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonanad, Clara, Esteve-Claramunt, Francisca, García-Blas, Sergio, Ayesta, Ana, Díez-Villanueva, Pablo, Pérez-Rivera, Jose-Ángel, Ferreiro, José Luis, Cánoves, Joaquim, López-Fornás, Francisco, Ariza Solé, Albert, Raposerias, Sergio, Vivas, David, Blanco, Regina, Bompart Berroterán, Daznia, Cordero, Alberto, Núñez, Julio, Fácila, Lorenzo, Núñez-Gil, Iván J., Górriz, José Luis, Bodí, Vicente, Martínez-Selles, Manuel, Ruiz Nodar, Juan Miguel, Chorro, Francisco Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181473/
https://www.ncbi.nlm.nih.gov/pubmed/35683397
http://dx.doi.org/10.3390/jcm11113008
Descripción
Sumario:The treatment of acute coronary syndrome (ACS) in elderly patients continues to be a challenge because of the characteS.G.B.ristics of this population and the lack of data and specific recommendations. This review summarizes the current evidence about critical points of oral antithrombotic therapy in elderly patients. To this end, we discuss the peculiarities and differences reported referring to dual antiplatelet therapy (DAPT) in ACS management in elderly patients and what might be the best option considering these population characteristics. Furthermore, we analyze antithrombotic strategies in patients with atrial fibrillation (AF), with a particular focus on those cases that also present coronary artery disease (CAD). It is imperative to deepen our knowledge regarding the management of these challenging patients through real-world data and specifically designed geriatric studies to help resolve the questions remaining in their disease management.